BSE Prices delayed by 5 minutes ! Prices as on   Apr 26, 2024   ABB India 6409.05 [ -0.41% ]ACC 2524.4 [ -2.14% ]Ambuja Cements 632.05 [ -0.99% ]Asian Paints Ltd. 2844.6 [ -0.59% ]Axis Bank Ltd. 1130.05 [ 0.24% ]Bajaj Auto 8965.5 [ 2.60% ]Bank of Baroda 268.15 [ -0.20% ]Bharti Airtel 1325.5 [ -0.78% ]Bharat Heavy Ele 278.8 [ 2.65% ]Bharat Petroleum 609.4 [ 0.94% ]Britannia Ind. 4797.55 [ -1.06% ]Cipla 1409.4 [ 0.28% ]Coal India 455.55 [ 0.62% ]Colgate Palm. 2855.25 [ 1.99% ]Dabur India 509 [ 0.44% ]DLF Ltd. 907.7 [ 1.47% ]Dr. Reddy's Labs 6253.25 [ 0.58% ]GAIL (India) 208.05 [ 0.00% ]Grasim Inds. 2345.4 [ -1.02% ]HCL Technologies 1472.3 [ -2.08% ]HDFC 2729.95 [ -0.62% ]HDFC Bank 1509.75 [ -0.06% ]Hero MotoCorp 4491.85 [ -0.01% ]Hindustan Unilever L 2221.5 [ -0.43% ]Hindalco Indus. 649.55 [ 0.47% ]ICICI Bank 1107.15 [ -0.53% ]IDFC L 127.25 [ 2.33% ]Indian Hotels Co 568.35 [ -1.54% ]IndusInd Bank 1445.85 [ -3.36% ]Infosys L 1430.15 [ -0.57% ]ITC Ltd. 439.95 [ 0.56% ]Jindal St & Pwr 931.95 [ -1.15% ]Kotak Mahindra Bank 1608.4 [ -2.11% ]L&T 3602.3 [ -1.32% ]Lupin Ltd. 1615.85 [ 1.31% ]Mahi. & Mahi 2044.25 [ -2.45% ]Maruti Suzuki India 12687.05 [ -1.70% ]MTNL 37.56 [ 0.29% ]Nestle India 2483.8 [ -3.08% ]NIIT Ltd. 107.9 [ 0.23% ]NMDC Ltd. 257.8 [ 2.18% ]NTPC 355.75 [ -0.71% ]ONGC 282.85 [ 0.28% ]Punj. NationlBak 136.45 [ 0.44% ]Power Grid Corpo 292.1 [ -0.34% ]Reliance Inds. 2903 [ -0.53% ]SBI 801.4 [ -1.38% ]Vedanta 396.65 [ 4.16% ]Shipping Corpn. 232.4 [ -0.15% ]Sun Pharma. 1504.25 [ -1.07% ]Tata Chemicals 1122.45 [ 0.92% ]Tata Consumer Produc 1102.9 [ -0.28% ]Tata Motors Ltd. 999.35 [ -0.14% ]Tata Steel 165.85 [ -1.04% ]Tata Power Co. 436.75 [ 1.22% ]Tata Consultancy 3812.85 [ -1.01% ]Tech Mahindra 1277.45 [ 7.34% ]UltraTech Cement 9700.2 [ 0.17% ]United Spirits 1199.7 [ 0.51% ]Wipro 464.65 [ 0.79% ]Zee Entertainment En 145.95 [ 2.24% ]

MARKETS

News Details

( As on 30/04/2021 11:18)

Dr. Reddy's Labs announces launch of Albendazole tablets in U.S.

Dr. Reddy's Laboratories along with its subsidiaries announced the launch of Albendazole Tablets, USP, a therapeutic equivalent generic version of Albenza Tablets, approved by the U.S. Food and Drug Administration (USFDA).

The Albenza brand and generic had U.S. sales of approximately $27 million MAT for the most recent twelve months ending in November 2020 according to IQVIA Health.

Dr. Reddy's Albendazole Tablets, USP are available in 200 mg tablets in bottle count sizes of two. Albenza is a trademark of Glaxosmithkline.

Albendazole is an anthelmintic drug indicated for treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium. Its also used for treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.

The announcement was made after market hours yesterday, 29 April 2021. Shares of Dr. Reddy's Laboratories rose 1.15% to settle at Rs 5,101.35 yesterday.

Dr. Reddy's Laboratories is an integrated pharmaceutical company. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations.